Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01777074
Other study ID # 113385
Secondary ID
Status Completed
Phase N/A
First received January 24, 2013
Last updated January 31, 2013
Start date November 2009
Est. completion date April 2012

Study information

Verified date January 2013
Source GlaxoSmithKline
Contact n/a
Is FDA regulated No
Health authority France: Haute Autorité de santé (HAS)
Study type Observational

Clinical Trial Summary

The present study is conducted in order to assess the acceptability of Hepatitis B vaccination in French general practitioners and peadiatricians before and after reimbursement of the paediatric vaccine InfanrixHexa. Two data measurement time points are planned, first before reimbursement and after reimbursement.


Description:

The aim of the study is to assess the acceptability of Hepatitis B immunization among general practitioners and open-care paediatricians. This is a national, repeated transversal epidemiological study with two data measurement time-points over a period of two years (T1 in 2009, T2 in 2011, two different samples of physicians) in order to assess immunization practices before introduction of the reimbursement of InfanrixHexa®, during the transition period and then during the period following reimbursement of the vaccine. At each collection time-point, two patient age groups will be investigated: 12-15 months and 24-27 months, thus providing measurements before/after reimbursement.


Recruitment information / eligibility

Status Completed
Enrollment 474
Est. completion date April 2012
Est. primary completion date April 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

• Children on the eligibility register complying with the investigator's immunization policy (children followed by the investigator since their birth, whose immunization regimen has been managed by the investigator).

Exclusion Criteria:

- Children on the eligibility register not complying with the investigator's immunization policy.

- Refusal of the patient.

Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Intervention

Other:
Data collection
Questionnaire, Vaccination book

Locations

Country Name City State
France GSK Investigational Site Agde cedex
France GSK Investigational Site Agen
France GSK Investigational Site Agen cedex
France GSK Investigational Site Aire sur la lys
France GSK Investigational Site Aizenay
France GSK Investigational Site Albi
France GSK Investigational Site Ales
France GSK Investigational Site Alleins
France GSK Investigational Site Amiens
France GSK Investigational Site Ancenis
France GSK Investigational Site Andresy
France GSK Investigational Site Angers
France GSK Investigational Site Anglet
France GSK Investigational Site Annecy
France GSK Investigational Site Annecy le vieux
France GSK Investigational Site Antony
France GSK Investigational Site Argenteuil
France GSK Investigational Site Arles
France GSK Investigational Site Arnas
France GSK Investigational Site Arsac
France GSK Investigational Site Asnieres sur seine
France GSK Investigational Site Aubagne
France GSK Investigational Site Aubergenville
France GSK Investigational Site Aubervilliers
France GSK Investigational Site Aucamville
France GSK Investigational Site Auchy les mines
France GSK Investigational Site Auriol
France GSK Investigational Site Avignon
France GSK Investigational Site Bagneux
France GSK Investigational Site Bagnols sur ceze
France GSK Investigational Site Bar le duc
France GSK Investigational Site Barr
France GSK Investigational Site Beaulieu les loches
France GSK Investigational Site Beaumont
France GSK Investigational Site Beaupreau
France GSK Investigational Site Beausoleil
France GSK Investigational Site Beauvais
France GSK Investigational Site Belfort
France GSK Investigational Site Bellegarde
France GSK Investigational Site Berre l etang
France GSK Investigational Site Besancon
France GSK Investigational Site Bethune
France GSK Investigational Site Betton
France GSK Investigational Site Beziers
France GSK Investigational Site Biarritz
France GSK Investigational Site Bievres
France GSK Investigational Site Biganos
France GSK Investigational Site Biscarrosse
France GSK Investigational Site Bischheim
France GSK Investigational Site Bois guillaume cedex
France GSK Investigational Site Bollene
France GSK Investigational Site Boos
France GSK Investigational Site Bordeaux
France GSK Investigational Site Bordeaux
France GSK Investigational Site Bosmie l aiguille
France GSK Investigational Site Boulogne billancourt
France GSK Investigational Site Bourg en bresse
France GSK Investigational Site Bousse
France GSK Investigational Site Brest
France GSK Investigational Site Bron
France GSK Investigational Site Bron
France GSK Investigational Site Bruges cedex
France GSK Investigational Site Buchy
France GSK Investigational Site Caen
France GSK Investigational Site Cambrai
France GSK Investigational Site Camphin en carembault
France GSK Investigational Site Cannes
France GSK Investigational Site Carresse Cassaber
France GSK Investigational Site Caveirac
France GSK Investigational Site Cergy
France GSK Investigational Site Cergy st christophe
France GSK Investigational Site Cestas
France GSK Investigational Site Chalamont
France GSK Investigational Site Challans
France GSK Investigational Site Chalon sur saone
France GSK Investigational Site Chambly
France GSK Investigational Site Champigny sur marne
France GSK Investigational Site Chanteloup les vignes
France GSK Investigational Site Chantilly
France GSK Investigational Site Chartres
France GSK Investigational Site Chassieu
France GSK Investigational Site Chateauneuf les martigues
France GSK Investigational Site Chatenois les forges
France GSK Investigational Site Chatou
France GSK Investigational Site Cherbourg - octeville
France GSK Investigational Site Clamart
France GSK Investigational Site Clapiers
France GSK Investigational Site Clermont Ferrand
France GSK Investigational Site Clermont ferrand
France GSK Investigational Site Clichy
France GSK Investigational Site Colmar
France GSK Investigational Site Colomars
France GSK Investigational Site Colombelles
France GSK Investigational Site Combs la ville
France GSK Investigational Site Compiegne
France GSK Investigational Site Conde sur noireau
France GSK Investigational Site Corbeil essonnes
France GSK Investigational Site Courpiere
France GSK Investigational Site Creutzwald
France GSK Investigational Site Crolles
France GSK Investigational Site Cugnaux
France GSK Investigational Site Cusset
France GSK Investigational Site Darnetal
France GSK Investigational Site Deluz
France GSK Investigational Site Dessenheim
France GSK Investigational Site Digne les bains
France GSK Investigational Site Divonne les bains
France GSK Investigational Site Domene
France GSK Investigational Site Domont
France GSK Investigational Site Draguignan
France GSK Investigational Site Einvaux
France GSK Investigational Site Epinal cedex 9
France GSK Investigational Site Equeurdreville hainneville
France GSK Investigational Site Esquerdes
France GSK Investigational Site Essey les Nancy
France GSK Investigational Site Estrees st denis
France GSK Investigational Site Evreux
France GSK Investigational Site Evry
France GSK Investigational Site Fecamp
France GSK Investigational Site Fenioux
France GSK Investigational Site Feurs
France GSK Investigational Site Figeac
France GSK Investigational Site Fontaine
France GSK Investigational Site Fontaine les dijon
France GSK Investigational Site Fontains
France GSK Investigational Site Fontenay sous bois
France GSK Investigational Site Forges les eaux
France GSK Investigational Site Fouesnant
France GSK Investigational Site Foussais payre
France GSK Investigational Site Francheville
France GSK Investigational Site Fumel
France GSK Investigational Site Gamarde les bains
France GSK Investigational Site Gemozac
France GSK Investigational Site Gondecourt
France GSK Investigational Site Gonneville la mallet
France GSK Investigational Site Gouvieux
France GSK Investigational Site Gouy sous bellonne
France GSK Investigational Site Gouzeaucourt
France GSK Investigational Site Grenoble
France GSK Investigational Site Greoux les bains
France GSK Investigational Site Grigny
France GSK Investigational Site Guenange
France GSK Investigational Site Haguenau
France GSK Investigational Site Hatten
France GSK Investigational Site Hesdin
France GSK Investigational Site Hoenheim
France GSK Investigational Site Houilles
France GSK Investigational Site Houplin ancoisne
France GSK Investigational Site Hyeres
France GSK Investigational Site Illkirch graffenstaden
France GSK Investigational Site Istres
France GSK Investigational Site Jarny
France GSK Investigational Site Joue les tours
France GSK Investigational Site L aigle
France GSK Investigational Site L huisserie
France GSK Investigational Site La chapelle sur erdre
France GSK Investigational Site La couronne
France GSK Investigational Site La creche
France GSK Investigational Site La garenne colombes
France GSK Investigational Site La madeleine
France GSK Investigational Site La meziere
France GSK Investigational Site La motte servolex
France GSK Investigational Site La source orleans
France GSK Investigational Site La talaudiere
France GSK Investigational Site La voulte sur rhone
France GSK Investigational Site Lamarche sur saone
France GSK Investigational Site Lambersart
France GSK Investigational Site Landivisiau
France GSK Investigational Site Lanester
France GSK Investigational Site Langon
France GSK Investigational Site Laval
France GSK Investigational Site Le barp
France GSK Investigational Site Le Bouscat
France GSK Investigational Site Le cannet
France GSK Investigational Site Le chesnay
France GSK Investigational Site Le creusot
France GSK Investigational Site Le havre
France GSK Investigational Site Le kremlin bicetre
France GSK Investigational Site Le lavandou
France GSK Investigational Site Le palais sur vienne
France GSK Investigational Site Le passage d' agen
France GSK Investigational Site Le rheu
France GSK Investigational Site Les sables d olonne
France GSK Investigational Site Les Sables D'olonne
France GSK Investigational Site Les ulis
France GSK Investigational Site Lesquin
France GSK Investigational Site Lille Cedex
France GSK Investigational Site Limas
France GSK Investigational Site Limoges
France GSK Investigational Site Lingolsheim
France GSK Investigational Site Lisieux
France GSK Investigational Site Lognes
France GSK Investigational Site Lomme
France GSK Investigational Site Loos en gohelle
France GSK Investigational Site Lorient
France GSK Investigational Site Luzinay
France GSK Investigational Site Lyon
France GSK Investigational Site Lyon
France GSK Investigational Site Lyon
France GSK Investigational Site Lyon
France GSK Investigational Site Malakoff
France GSK Investigational Site Mantes la ville
France GSK Investigational Site Marchenoir
France GSK Investigational Site Marcq en baroeul
France GSK Investigational Site Marguerittes
France GSK Investigational Site Marmande
France GSK Investigational Site Marnay
France GSK Investigational Site Marseille
France GSK Investigational Site Marseille
France GSK Investigational Site Marseille
France GSK Investigational Site Marseille
France GSK Investigational Site Marseille
France GSK Investigational Site Marseille
France GSK Investigational Site Martigues
France GSK Investigational Site Martin eglise
France GSK Investigational Site Martinsart
France GSK Investigational Site Mauze sur mignon
France GSK Investigational Site Meaux
France GSK Investigational Site Merignac
France GSK Investigational Site Merkwiller pechelbronn
France GSK Investigational Site Mery sur oise
France GSK Investigational Site Metz
France GSK Investigational Site Meudon
France GSK Investigational Site Meylan
France GSK Investigational Site Meyssac
France GSK Investigational Site Mirecourt
France GSK Investigational Site Moivrons
France GSK Investigational Site Molsheim
France GSK Investigational Site Mondeville
France GSK Investigational Site Mons en baroeul
France GSK Investigational Site Montauban
France GSK Investigational Site Montelimar
France GSK Investigational Site Monteux
France GSK Investigational Site Montfermeil
France GSK Investigational Site Montgeron
France GSK Investigational Site Montigny le bretonneux
France GSK Investigational Site Montigny les metz
France GSK Investigational Site Montoire sur le loir
France GSK Investigational Site Montpellier
France GSK Investigational Site Montpellier
France GSK Investigational Site Montreuil
France GSK Investigational Site Morlaas
France GSK Investigational Site Morlaix
France GSK Investigational Site Mornas
France GSK Investigational Site Mouans sartoux
France GSK Investigational Site Moutiers tarentaise
France GSK Investigational Site Moyeuvre grande
France GSK Investigational Site Mur de sologne
France GSK Investigational Site Nanterre
France GSK Investigational Site Nantes
France GSK Investigational Site Nemours
France GSK Investigational Site Neuville sur saone
France GSK Investigational Site Niort
France GSK Investigational Site Nogent sur marne
France GSK Investigational Site Noisy le roi
France GSK Investigational Site Noyon
France GSK Investigational Site Obernai
France GSK Investigational Site Oloron ste marie
France GSK Investigational Site Orleans
France GSK Investigational Site Orleans
France GSK Investigational Site Orthez
France GSK Investigational Site Oucques
France GSK Investigational Site Ouistreham
France GSK Investigational Site Oust
France GSK Investigational Site Ozoir la ferriere
France GSK Investigational Site Palaiseau
France GSK Investigational Site Pamiers
France GSK Investigational Site Paris
France GSK Investigational Site Paris
France GSK Investigational Site Paris
France GSK Investigational Site Paris
France GSK Investigational Site Paris
France GSK Investigational Site Paris
France GSK Investigational Site Paris
France GSK Investigational Site Paris
France GSK Investigational Site Paris
France GSK Investigational Site Paris
France GSK Investigational Site Paris
France GSK Investigational Site Paris
France GSK Investigational Site Paris
France GSK Investigational Site Pau
France GSK Investigational Site Pau cedex
France GSK Investigational Site Pertuis
France GSK Investigational Site Pierrefitte sur sauldre
France GSK Investigational Site Plouguernevel
France GSK Investigational Site Pont a mousson
France GSK Investigational Site Pont l abbe d arnoult
France GSK Investigational Site Pont ste maxence
France GSK Investigational Site Pontarlier
France GSK Investigational Site Pornic
France GSK Investigational Site Port sur saone
France GSK Investigational Site Provins
France GSK Investigational Site Publier
France GSK Investigational Site Puteaux
France GSK Investigational Site Quevreville la poterie
France GSK Investigational Site Raches
France GSK Investigational Site Rennes
France GSK Investigational Site Rennes
France GSK Investigational Site Rennes
France GSK Investigational Site Reze
France GSK Investigational Site Rillieux la pape
France GSK Investigational Site Riom
France GSK Investigational Site Rivery
France GSK Investigational Site Roanne
France GSK Investigational Site Roche la moliere
France GSK Investigational Site Rodez
France GSK Investigational Site Romainville
France GSK Investigational Site Romans sur isere
France GSK Investigational Site Romille
France GSK Investigational Site Ronchin
France GSK Investigational Site Rosieres en santerre
France GSK Investigational Site Rouen
France GSK Investigational Site Royan
France GSK Investigational Site Ruy
France GSK Investigational Site Sahurs
France GSK Investigational Site Saint-Aubin
France GSK Investigational Site Saintes
France GSK Investigational Site Sanary sur mer
France GSK Investigational Site Segonzac
France GSK Investigational Site Segré
France GSK Investigational Site Selestat
France GSK Investigational Site Sens
France GSK Investigational Site Septemes les vallons
France GSK Investigational Site Serres
France GSK Investigational Site Sillery
France GSK Investigational Site Soissons
France GSK Investigational Site Sorgues
France GSK Investigational Site St astier
France GSK Investigational Site St aubin sur scie
France GSK Investigational Site St brevin les pins
France GSK Investigational Site St brieuc
France GSK Investigational Site St chamond
France GSK Investigational Site St cheron
France GSK Investigational Site St cloud
France GSK Investigational Site St cyr au mont d'or
France GSK Investigational Site St denis
France GSK Investigational Site St etienne
France GSK Investigational Site St etienne de montluc
France GSK Investigational Site St flour
France GSK Investigational Site St genis laval
France GSK Investigational Site St germain les arpajon
France GSK Investigational Site St herblain
France GSK Investigational Site St ismier
France GSK Investigational Site St jean
France GSK Investigational Site St jean de la ruelle
France GSK Investigational Site St leu la foret
France GSK Investigational Site St louis
France GSK Investigational Site St loup sur semouse
France GSK Investigational Site St malo
France GSK Investigational Site St nazaire
France GSK Investigational Site St pierre d irube
France GSK Investigational Site St pol sur mer
France GSK Investigational Site St priest
France GSK Investigational Site St remy de provence
France GSK Investigational Site St tropez
France GSK Investigational Site Ste foy la grande
France GSK Investigational Site Ste maxime
France GSK Investigational Site Strasbourg
France GSK Investigational Site Strasbourg
France GSK Investigational Site Strasbourg cedex
France GSK Investigational Site Sucy en brie
France GSK Investigational Site Suresnes
France GSK Investigational Site Talence
France GSK Investigational Site Tarascon
France GSK Investigational Site Thiais
France GSK Investigational Site Thonon les bains
France GSK Investigational Site Thun st amand
France GSK Investigational Site Toul
France GSK Investigational Site Toulon
France GSK Investigational Site Toulon
France GSK Investigational Site Toulouse
France GSK Investigational Site Tours
France GSK Investigational Site Trie chateau
France GSK Investigational Site Troyes
France GSK Investigational Site Vabres l abbaye
France GSK Investigational Site Val de vesle
France GSK Investigational Site Valence
France GSK Investigational Site Vallauris
France GSK Investigational Site Vandoeuvre les nancy
France GSK Investigational Site Vannes
France GSK Investigational Site Vannes cedex
France GSK Investigational Site Vaugneray
France GSK Investigational Site Vaulx en velin
France GSK Investigational Site Vaureal
France GSK Investigational Site Vaux le penil
France GSK Investigational Site Vendargues
France GSK Investigational Site Vernouillet
France GSK Investigational Site Versailles
France GSK Investigational Site Vertou
France GSK Investigational Site Villars les Dombes
France GSK Investigational Site Villeblevin
France GSK Investigational Site Villeneuve d ascq cedex
France GSK Investigational Site Villeurbanne cedex
France GSK Investigational Site Villiers sur marne
France GSK Investigational Site Vincennes
France GSK Investigational Site Viry chatillon
France GSK Investigational Site Vitrolles
France GSK Investigational Site Vitry sur Seine
France GSK Investigational Site Voreppe
France GSK Investigational Site Wattignies
France GSK Investigational Site Yerres
France GSK Investigational Site Zillisheim

Sponsors (1)

Lead Sponsor Collaborator
GlaxoSmithKline

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in the proportion of physicians with at least 50% of infants immunized against Hepatitis B. 4 years No
Secondary Type of physicians, based on the questionnaire regarding immunization practices and established at each measurement time point. 4 years No
See also
  Status Clinical Trial Phase
Completed NCT01182311 - Duration of Long-term Immunity After Hepatitis B Virus Immunization
Completed NCT04971928 - Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic Impairment Phase 1
Completed NCT03285620 - A Study of AL-034 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses in Healthy Participants Phase 1
Completed NCT01884415 - Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis Phase 3
Recruiting NCT05404919 - Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates Phase 2
Completed NCT02153320 - Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers Phase 1
Completed NCT00352963 - Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age). Phase 3
Completed NCT03567382 - Arresting Vertical Transmission of Hepatitis B Virus Phase 4
Not yet recruiting NCT04056728 - A Phase IV Study to Assess the Safety of EupentaTM Inj Phase 4
Not yet recruiting NCT03604016 - Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver Phase 4
Completed NCT00753649 - Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants Phase 4
Recruiting NCT03027258 - Point-of-Delivery Prenatal Test Results Through mHealth to Improve Birth Outcome N/A
Terminated NCT02604199 - A Multi-dose Study of ARC-520 in Patients With Hepatitis B 'e' Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection Phase 2
Completed NCT02540538 - Safety and Immunogenicity of HBAI20 Hepatitis B Vaccine in Naive Adults and Non-responders Phase 1
Completed NCT02169674 - Hepatitis B Booster Study in Adolescence Phase 4
Completed NCT02421666 - A Comparative Trial of Improving Care for Underserved Asian Americans Infected With HBV N/A
Completed NCT01917357 - A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject Phase 3
Completed NCT01732354 - Study for Consolidation Period of Chronic Hepatitis B
Completed NCT01368497 - Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection Phase 3
Recruiting NCT01462981 - Cohort of Hepatitis B Research of Amsterdam N/A